Appointment booking for Dr. Russell Pearlman, OD is currently not available.Dr. Russell Pearlman, OD has not yet fully activated their profile on DiabetesIQ.
Dr. Russell Pearlman, OD (he/him) is a Optometrist in Sterling, VA with over 18 years of experience. What is your opinion of Dr. Russell Pearlman, OD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Russell Pearlman, OD has received over $1,794 which includes payments from the following companies:
$356.23 from Allergan Inc.
$298.68 from Alcon Laboratories Inc
$233.75 from Bausch & Lomb, a division of Bausch Health US, LLC
$180.86 from Sun Pharmaceutical Industries Inc.
$130.92 from Valeant Pharmaceuticals North America LLC
$118.00 from Novartis Pharmaceuticals Corporation
$93.77 from Shire North American Group Inc
$83.75 from Rapid PAthogen Screening, Inc.
$62.33 from Abbott Laboratories
$53.33 from Aerie Pharmaceuticals, Inc.
$41.63 from Bausch and Lomb Inc.
$40.26 from TissueTech, Inc.
$30.41 from CooperVision Inc.
$26.93 from Alimera Sciences, Inc.
$16.67 from TearLab Corp
$14.73 from Kala Pharmaceuticals, Inc.
$12.04 from Quidel Corporation
Payments received by Dr. Russell Pearlman, OD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!